UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside

Biochimica et biophysica acta. Reviews on cancer, 2020-12, Vol.1874 (2), p.188447-188447, Article 188447

2020

Volltextzugriff (PDF)

Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review

International journal of molecular sciences, 2023-07, Vol.24 (15), p.12030

2023

Volltextzugriff (PDF)

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death

Frontiers in oncology, 2022-10, Vol.12, p.1018775-1018775

2022

Volltextzugriff (PDF)

Cortical aPKC kinase activity distinguishes neural stem cells from progenitor cells by ensuring asymmetric segregation of Numb

Developmental biology, 2012-05, Vol.365 (1), p.219-228

2012

Volltextzugriff (PDF)

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

Clinical case reports, 2020-10, Vol.8 (10), p.1984-1987

2020

Volltextzugriff (PDF)

An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer

Clinical colorectal cancer, 2024-08

2024

Volltextzugriff (PDF)

CDK9 inhibitors for the treatment of solid tumors

Biochemical pharmacology, 2024-11, Vol.229, p.116470, Article 116470

2024

Volltextzugriff (PDF)

Impact of adjuvant chemotherapy on outcomes after curative-intent surgery for biliary tract cancer: A 10-year retrospective single-center study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16273-e16273

2024

Volltextzugriff (PDF)

The interaction of radiotherapy and dual inhibition of BET and HAT/p300 in colorectal cancer

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.146-146

2024

Volltextzugriff (PDF)

Impact of somatic genomic alterations in patients with metastatic colorectal cancer in a minority-rich academic medical center

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.215-215

2024

Volltextzugriff (PDF)

Abstract 1763: NEO2734, a novel dual bromodomain and histone acetyltransferase inhibitor, in the treatment of colorectal cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1763-1763

2020

Volltextzugriff (PDF)

1845: HCV as a favorable prognostic factor in HCC treated with SBRT: systematic review and meta-analysis

Radiotherapy and oncology, 2024-05, Vol.194, p.S2210-S2213

2024

Volltextzugriff (PDF)

Safety and efficacy of liposomal irinotecan as the second-line treatment for advanced pancreatic cancer: A systematic review and meta-analysis

Critical reviews in oncology/hematology, 2024-09, Vol.201, p.104386, Article 104386

2024

Volltextzugriff (PDF)

Association of patient and disease characteristics with outcomes of regorafenib in patients with metastatic colorectal cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.135-135

2023

Volltextzugriff (PDF)

Mcl-1 inhibition overcomes intrinsic and acquired regorafenib resistance in colorectal cancer

Theranostics, 2020-01, Vol.10 (18), p.8098-8110

2020

Volltextzugriff (PDF)

Plant-Based Diet and Survival Among Patients with Metastatic Colorectal Cancer

JNCI : Journal of the National Cancer Institute, 2024-08

2024

Volltextzugriff (PDF)

Biomarker analysis for UPCI 14-118: Phase II study of pembrolizumab in combination with azacitidine in patients with refractory metastatic colorectal cancer

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.173-173

2020

Volltextzugriff (PDF)

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

Clinical epigenetics, 2022-01, Vol.14 (1), p.3, Article 3

2022

Volltextzugriff (PDF)

Abstract 1218: CDK9 inhibitors modulate the transcriptional landscape of colorectal cancer to suppress MAPK signaling and synergizes with BRAF inhibitors to treat BRAF-mutant colorectal cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.1218-1218

2024

Volltextzugriff (PDF)

Abstract 2200: Plant-based diet and survival among patients with metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance)

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.2200-2200

2024

Volltextzugriff (PDF)

A novel fizzy/Cdc20-dependent mechanism suppresses necrosis in neural stem cells

Development (Cambridge), 2014-04, Vol.141 (7), p.1453-1464

2014

Volltextzugriff (PDF)

Nitric Oxide-Induced Fluorescence Enhancement by Displacement of Dansylated Ligands from Cobalt

Chembiochem : a European journal of chemical biology, 2006-10, Vol.7 (10), p.1571-1576

2006

Volltextzugriff (PDF)

Intravascular Lymphoma - The Creepy Crawler: A Case Series and Brief Literature Review

Cancer diagnosis & prognosis, 2023-01, Vol.3 (1), p.31-37

2023

Volltextzugriff (PDF)

Intravascular Lymphoma - The Creepy Crawler: A Case Series and Brief Literature Review

Cancer diagnosis & prognosis, 2023, Vol.3 (1), p.31-37

2023

Volltextzugriff (PDF)

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

Clinical case reports, 2020, Vol.8 (10), p.1984-1987

2020

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)
Berichte
(2)

Sprache

Englisch
(26)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside

Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death

Cortical aPKC kinase activity distinguishes neural stem cells from progenitor cells by ensuring asymmetric segregation of Numb

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer

CDK9 inhibitors for the treatment of solid tumors

Impact of adjuvant chemotherapy on outcomes after curative-intent surgery for biliary tract cancer: A 10-year retrospective single-center study

The interaction of radiotherapy and dual inhibition of BET and HAT/p300 in colorectal cancer

Impact of somatic genomic alterations in patients with metastatic colorectal cancer in a minority-rich academic medical center

Abstract 1763: NEO2734, a novel dual bromodomain and histone acetyltransferase inhibitor, in the treatment of colorectal cancer

1845: HCV as a favorable prognostic factor in HCC treated with SBRT: systematic review and meta-analysis

Safety and efficacy of liposomal irinotecan as the second-line treatment for advanced pancreatic cancer: A systematic review and meta-analysis

Association of patient and disease characteristics with outcomes of regorafenib in patients with metastatic colorectal cancer

Mcl-1 inhibition overcomes intrinsic and acquired regorafenib resistance in colorectal cancer

Plant-Based Diet and Survival Among Patients with Metastatic Colorectal Cancer

Biomarker analysis for UPCI 14-118: Phase II study of pembrolizumab in combination with azacitidine in patients with refractory metastatic colorectal cancer

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

Abstract 1218: CDK9 inhibitors modulate the transcriptional landscape of colorectal cancer to suppress MAPK signaling and synergizes with BRAF inhibitors to treat BRAF-mutant colorectal cancer

Abstract 2200: Plant-based diet and survival among patients with metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance)

A novel fizzy/Cdc20-dependent mechanism suppresses necrosis in neural stem cells

Nitric Oxide-Induced Fluorescence Enhancement by Displacement of Dansylated Ligands from Cobalt

Intravascular Lymphoma - The Creepy Crawler: A Case Series and Brief Literature Review

Intravascular Lymphoma - The Creepy Crawler: A Case Series and Brief Literature Review

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

Suchergebnisse filtern